Zosano Pharma Corporation
ZSAN
ZSAN was delisted on the 10th of June, 2022.
43 hedge funds and large institutions have $23.1M invested in Zosano Pharma Corporation in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 14 increasing their positions, 1 reducing their positions, and 4 closing their positions.
1,300% more repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 1
300% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 4
289% more capital invested
Capital invested by funds: $5.92M → $23.1M (+$17.1M)
39% more funds holding
Funds holding: 31 → 43 (+12)
5.15% more ownership
Funds ownership: 12.71% → 17.86% (+5.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.38M |
| 2 |
Morgan Stanley
New York
|
+$1.67M |
| 3 |
JSMC
Jess S. Morgan & Co
Los Angeles,
California
|
+$1.56M |
| 4 |
BlackRock
New York
|
+$705K |
| 5 |
CCM
CAAS Capital Management
New York
|
+$603K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ARTA
A.R.T. Advisors
New York
|
-$21K |
| 2 |
Goldman Sachs
New York
|
-$9.73K |
| 3 |
GPFA
Game Plan Financial Advisors
Westlake,
Ohio
|
-$9K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$9K |
| 5 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$1K |
ZSAN Hedge Fund Activity: Q3 2020 in Review
43 of the 4,971 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q3 2020, worth a combined $23.1M — up 289% from $5.92M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new ZSAN positions and 4 closed out — a net gain of 12 holders — while 14 added to existing stakes and 1 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.38M. The largest seller was A.R.T. Advisors, exiting entirely with an estimated $21K sold.
- 43 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q3 2020, up from 31 in Q2 2020.
- Funds reported $23.1M of Zosano Pharma Corporation stock for Q3 2020, up 289% quarter-over-quarter.
- 16 funds opened new Zosano Pharma Corporation positions in Q3 2020 and 4 closed out, a net change of +12 holders.
- The largest Zosano Pharma Corporation buyer in Q3 2020 was Vanguard Group, an estimated $2.38M added.
- The largest Zosano Pharma Corporation seller in Q3 2020 was A.R.T. Advisors, an estimated $21K sold.
Based on aggregated 13F filings for Q3 2020.